HealthCare Global Enterprises Reports Strong Q1 FY25 Results With 14 Per Cent Revenue Growth

HealthCare Global Enterprises  (HCG), a leading provider of speciality healthcare services in oncology and fertility in India, has announced its financial results for the first quarter of FY25.

In a press statement on Friday,  the company informed that it reported a revenue of Rs 5,256 million, marking a 14 per cent year-on-year growth. EBITDA for the quarter was Rs 929 million, reflecting a 21 per cent increase from the previous year, and PAT surged by 59 per cent to Rs 121 million.

In the quarterly report ending June 30th, 2024, HCG demonstrated notable financial performance improvements across key metrics. The revenue increased from Rs 4,607 million in Q1 FY24 to Rs 5,256 million in Q1 FY25. Adjusted EBITDA grew from Rs 765 million to Rs 929 million, while Reported EBITDA rose from Rs 743 million to Rs 909 million. Notably, PAT soared from Rs 76 million to Rs 121 million.

HCG’s results also included significant operational updates. The Average Revenue Per Occupied Bed (ARPOB) rose to Rs 44,342, a 12 per cent increase year-on-year. The overall Average Occupancy Rate (AOR) slightly decreased to 65.6 per cent from 66.9 per cent in the previous year. The Return on Capital Employed (RoCE) for established centres stood at 14.1 per cent while emerging centres improved to -9.3 per cent.

Regions like Kolkata, Nagpur, South Mumbai, Nashik, and Bhavnagar demonstrated high revenue growth, with Kolkata achieving a remarkable 73 per cent increase.

Dr B.S. Ajaikumar, Executive Chairman of HealthCare Global Enterprises ., commented, “As planned, we continue to deliver strong financials and operational excellence across our network. The acquisition of the Mahatma Gandhi Cancer Hospital and Research Institute in Vizag will play a crucial role in our growth. Our commitment to innovation and quality care is unwavering, and we are proud of the strides we have made in enhancing patient outcomes.”

Raj Gore, CEO of HealthCare Global Enterprises , added, “We are pleased with our revenue growth of 16.7 per cent year-over-year, excluding discontinued operations. Our EBITDA growth and margin improvements underscore the operational efficiencies we have achieved. The progress in our emerging centres, particularly in Kolkata, positions us well for continued growth and success.”